These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28464417)

  • 1. A Novel Semiautomated Pipeline to Measure Brain Atrophy and Lesion Burden in Multiple Sclerosis: A Long-Term Comparative Study.
    Uher T; Krasensky J; Vaneckova M; Sobisek L; Seidl Z; Havrdova E; Bergsland N; Dwyer MG; Horakova D; Zivadinov R
    J Neuroimaging; 2017 Nov; 27(6):620-629. PubMed ID: 28464417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of High-Frequency MRI Monitoring in the Detection of Brain Atrophy in Multiple Sclerosis.
    Uher T; Krasensky J; Sobisek L; Seidl Z; Bergsland N; Dwyer MG; Kubala Havrdova E; Zivadinov R; Horakova D; Vaneckova M
    J Neuroimaging; 2018 May; 28(3):328-337. PubMed ID: 29485230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset.
    Storelli L; Pagani E; Pantano P; Piervincenzi C; Tedeschi G; Gallo A; De Stefano N; Battaglini M; Rocca MA; Filippi M;
    J Magn Reson Imaging; 2023 Oct; 58(4):1221-1231. PubMed ID: 36661195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Brain Volume Measured from 1.5T versus 3T MRI in Healthy Subjects and Patients with Multiple Sclerosis.
    Chu R; Tauhid S; Glanz BI; Healy BC; Kim G; Oommen VV; Khalid F; Neema M; Bakshi R
    J Neuroimaging; 2016; 26(1):62-7. PubMed ID: 26118637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpretation of Brain Volume Increase in Multiple Sclerosis.
    Uher T; Bergsland N; Krasensky J; Dwyer MG; Andelova M; Sobisek L; Havrdova EK; Horakova D; Zivadinov R; Vaneckova M
    J Neuroimaging; 2021 Mar; 31(2):401-407. PubMed ID: 33314460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach.
    Uher T; Vaneckova M; Sormani MP; Krasensky J; Sobisek L; Dusankova JB; Seidl Z; Havrdova E; Kalincik T; Benedict RH; Horakova D
    Eur J Neurol; 2017 Feb; 24(2):292-301. PubMed ID: 27873386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing Biological and Methodological Aspects of Brain Volume Loss in Multiple Sclerosis.
    Andorra M; Nakamura K; Lampert EJ; Pulido-Valdeolivas I; Zubizarreta I; Llufriu S; Martinez-Heras E; Sola-Valls N; Sepulveda M; Tercero-Uribe A; Blanco Y; Saiz A; Villoslada P; Martinez-Lapiscina EH
    JAMA Neurol; 2018 Oct; 75(10):1246-1255. PubMed ID: 29971335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of MRI coregistration on serial short-term brain volume changes in multiple sclerosis.
    Fritz DA; Dwyer MG; Bagnato F; Watts KL; Bratina A; Zorzon M; Durastanti V; Locatelli L; Millefiorini E; Zivadinov R
    Neurol Res; 2006 Apr; 28(3):275-9. PubMed ID: 16687053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological software tool for reliable atrophy measurement (NeuroSTREAM) of the lateral ventricles on clinical-quality T2-FLAIR MRI scans in multiple sclerosis.
    Dwyer MG; Silva D; Bergsland N; Horakova D; Ramasamy D; Durfee J; Vaneckova M; Havrdova E; Zivadinov R
    Neuroimage Clin; 2017; 15():769-779. PubMed ID: 28706852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agreement of MSmetrix with established methods for measuring cross-sectional and longitudinal brain atrophy.
    Steenwijk MD; Amiri H; Schoonheim MM; de Sitter A; Barkhof F; Pouwels PJW; Vrenken H
    Neuroimage Clin; 2017; 15():843-853. PubMed ID: 28794970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal associations between brain structural changes and fatigue in early MS.
    Nourbakhsh B; Azevedo C; Nunan-Saah J; Maghzi AH; Spain R; Pelletier D; Waubant E
    Mult Scler Relat Disord; 2016 Jan; 5():29-33. PubMed ID: 26856940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic estimation of brain parenchymal fraction in patients with multple sclerosis: a comparison between synthetic MRI and an established automated brain segmentation software based on FSL.
    Yazici I; Krieger B; Bellenberg B; Ladopoulos T; Gold R; Schneider R; Lukas C
    Neuroradiology; 2024 Feb; 66(2):193-205. PubMed ID: 38110539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Observational Study to Assess Brain MRI Change and Disease Progression in Multiple Sclerosis Clinical Practice-The MS-MRIUS Study.
    Zivadinov R; Khan N; Medin J; Christoffersen P; Price J; Korn JR; Bonzani I; Dwyer MG; Bergsland N; Carl E; Silva D; Weinstock-Guttman B
    J Neuroimaging; 2017 May; 27(3):339-347. PubMed ID: 27918139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of Whole-Brain and Gray Matter Atrophy in Multiple Sclerosis: Assessment with MR Imaging.
    Storelli L; Rocca MA; Pagani E; Van Hecke W; Horsfield MA; De Stefano N; Rovira A; Sastre-Garriga J; Palace J; Sima D; Smeets D; Filippi M;
    Radiology; 2018 Aug; 288(2):554-564. PubMed ID: 29714673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multimodal approach to assess the validity of atrophied T2-lesion volume as an MRI marker of disease progression in multiple sclerosis.
    Tavazzi E; Bergsland N; Kuhle J; Jakimovski D; Ramanathan M; Maceski AM; Tomic D; Hagemeier J; Kropshofer H; Leppert D; Dwyer MG; Weinstock-Guttman B; Benedict RHB; Zivadinov R
    J Neurol; 2020 Mar; 267(3):802-811. PubMed ID: 31768628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central Atrophy Early in Multiple Sclerosis: Third Ventricle Volumetry versus Planimetry.
    Lutz T; Bellenberg B; Schneider R; Weiler F; Köster O; Lukas C
    J Neuroimaging; 2017 May; 27(3):348-354. PubMed ID: 27897360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
    Stevenson VL; Smith SM; Matthews PM; Miller DH; Thompson AJ
    J Neurol; 2002 Feb; 249(2):171-7. PubMed ID: 11985382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A validation study of manual atrophy measures in patients with Multiple Sclerosis.
    Cappelle S; Pareto D; Tintoré M; Vidal-Jordana A; Alyafeai R; Alberich M; Sastre-Garriga J; Auger C; Montalban X; Rovira À
    Neuroradiology; 2020 Aug; 62(8):955-964. PubMed ID: 32246177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study.
    Lorefice L; Frau J; Coghe G; Pitzalis R; Gessa I; Contu F; Barracciu MA; Marrosu MG; Cocco E; Fenu G
    Mult Scler Relat Disord; 2019 Jan; 27():74-78. PubMed ID: 30343253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.